Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Quest Diagnostics Inc reaffirms FY 2013 revenue guidance and updates FY 2013 EPS guidance


Thursday, 12 Dec 2013 05:36pm EST 

Quest Diagnostics Inc:Sees fiscal 2013 revenues to be about 3.5% below the prior year, which is unchanged from its prior guidance;.Sees fiscal 2013 adjusted earnings per diluted share (EPS) to be between $3.90 and $3.95, compared to previous guidance of between $3.85 and $3.95.Fiscal 2013 revenue of $7.128 bln and EPS of $3.90 - Thomson Reuters I/B/E/S. 

Company Quote

67.94
-0.16 -0.23%
24 Dec 2014